Tag: dna

Trump To Trans Males “You Can Never Become A Woman”

President Trump gave a stark biology lesson Wednesday as he told those gathered at the White House that trans-identified males “can never become a woman.”

“No matter how many surgeries you have or chemicals you inject, if you’re born with male DNA in every cell of your body, you can never become a woman,” Trump asserted.

“You’re not gonna become a woman,” Trump reiterated, drawing raucous cheers from the audience.

“And that’s why last month, I proudly signed a historic executive order to ban men from competing in women’s sports, and it was very popular,” he added.

The President was speaking in honour of women’s history month.

While citing American women he called “legends,” including Betsy Ross, Harriet Tubman, Susan B Anthony, Clara Barton, and Amelia Earhart, Trump also noted there are “more women in our cabinet than any Republican president in the history of our country.”

Those women include Susie Wiles, Karoline Leavitt, Alina Habba, Pam Bondi, Brooke Rollins, and Linda McMahon.

Referring to the previous regime, which now seems like a distant nightmare,Trump said “For four long years, we had an administration that tried to abolish the very concept of womanhood and replace it with radical gender ideology.”

“Maybe you heard something about that,” he continued, adding “They destroyed women’s spaces and even tried to replace the word mother with the term ‘birther person’, the mother became a ‘birther person’. What’s that all about?”

Trump further related how he had seen a Democrat Rep. on TV desperately trying to defend trans-identified males in women’s sports. 

“I said, this guy is going to lose. He’s going to lose badly,” the President noted, adding “The whole party is still into that. They haven’t learned, we don’t want him to learn, frankly, we want him to keep fighting.”

“Let’s not tell him under the Trump administration, we’re ending the Marxist war on women, and you had a war on women, and we’re protecting women’s rights, defending women’s dignity, and standing up for the American moms and daughters,” Trump urged.

Keep reading

23andMe Files For Bankruptcy, CEO Resigns – Fate Of Americans’ DNA Data Now In Court-Supervised Sale

Shares of 23andMe crashed in premarket trading on Monday after the genetic testing unicorn startup filed for bankruptcy in the US Bankruptcy Court for the Eastern District of Missouri, following a slide in demand for its ancestry kits and a data breach. The bankruptcy raises one alarming question about DNA security: What will happen to the genetic data of the company’s more than 15 million customers?

23andMe announced that its CEO, Anne Wojcicki, has resigned immediately and will remain on the company’s board of directors. She led the cash-burning startup that never turned a profit and once commanded a market capitalization of nearly $6 billion in late 2021. Shares plunged 44% in the premarket to $1.

“After a thorough evaluation of strategic alternatives, we have determined that a court-supervised sale process is the best path forward to maximize the value of the business,” Mark Jensen, Chair and member of the Special Committee of the Board of Directors wrote in a statement. 

Jensen said, “We expect the court-supervised process will advance our efforts to address the operational and financial challenges we face, including further cost reductions and the resolution of legal and leasehold liabilities. We believe in the value of our people and our assets and hope that this process allows our mission of helping people access, understand and benefit from the human genome to live on for the benefit of customers and patients.”

“We want to thank our employees for their dedication to 23andMe’s mission. We are committed to supporting them as we move through the process. In addition, we are committed to continuing to safeguard customer data and being transparent about the management of user data going forward, and data privacy will be an important consideration in any potential transaction,” he added.

Keep reading

Genetic Study Reveals Hidden Chapter in Story of Human Evolution

Modern humans descended from not one, but at least two ancestral populations that drifted apart and later reconnected, long before modern humans spread across the globe.

Using advanced analysis based on full genome sequences, researchers from the University of Cambridge have found evidence that modern humans are the result of a genetic mixing event between two ancient populations that diverged around 1.5 million years ago. About 300,000 years ago, these groups came back together, with one group contributing 80% of the genetic makeup of modern humans and the other contributing 20%.

For the last two decades, the prevailing view in human evolutionary genetics has been that Homo sapiens first appeared in Africa around 200,000 to 300,000 years ago, and descended from a single lineage. However, these latest results, reported in the journal  Nature Genetics, suggest a more complex story.

“The question of where we come from is one that has fascinated humans for centuries,” said first author Dr Trevor Cousins from Cambridge’s Department of Genetics. “For a long time, it’s been assumed that we evolved from a single continuous ancestral lineage, but the exact details of our origins are uncertain.”

Keep reading

Hoping to revive mammoths, scientists create ‘woolly mice’

Scientists have genetically engineered mice with some key characteristics of an extinct animal that was far larger — the woolly mammoth.

This “woolly mouse” marks an important step toward achieving the researchers’ ultimate goal — bringing a woolly mammoth-like creature back from extinction, they say.

“For us, it’s an incredibly big deal,” says Beth Shapiro, chief science officer at Colossal Biosciences, a Dallas company trying to resurrect the woolly mammoth and other extinct species.

The company announced the creation of the woolly mice Tuesday in a news release and posted a scientific paper online detailing the achievement. Scientists implanted genetically modified embryos in female lab mice that gave birth to the first of the woolly pups in October.

“This is really validation that what we have in mind for our longer-term de-extinction project is really going to work,” Shapiro told NPR in an interview. The company says reviving extinct species like the mammoth, the dodo and others could help repair ecosystems. Critics, however, question whether de-extinction would be safe for the animals or environment.

Shapiro and her colleagues started by trying to identify the genes responsible for making mammoths distinctive. They compared ancient samples of genetic material from mammoths with genetic sequences of African and Asian elephants, the mammoth’s closest living relative.

These included long, woolly hair and a way of metabolizing fat that helped the animals survive well in the cold.

Keep reading

DNA Contamination Study — Conducted at FDA Lab by Students Supervised by FDA Scientists — ‘Doesn’t Belong to FDA’ Agency Says

The U.S. Food and Drug Administration (FDA) has responded to a peer-reviewed study conducted within its own laboratory, which uncovered excessively high levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccine.

The study revealed that residual DNA levels exceeded regulatory limits by six to 470 times, validating earlier studies from independent researchers that the FDA had previously disregarded.

Published by students in the Journal of High School Science, the study has garnered significant attention since the story broke, with its altimetric score rivaling those of major studies in leading medical journals.

Despite the study being conducted at the FDA’s White Oak campus in Maryland, the agency has sought to distance itself from the findings.

A spokesperson stated that the study “does not belong to the FDA” and is therefore not theirs to disclose.

“The FDA does not comment on individual studies,” the spokesperson added, declining to acknowledge the new scientific findings.

The agency also refused to address the involvement of three of its own scientists — Shuliang Liu, Ph.D., Tony Wang, M.D., and Prabhuanand Selvaraj, Ph.D. — who supervised the students conducting the study.

When questioned about potential regulatory actions, such as issuing a public alert, recalling affected vaccine batches, or notifying other agencies, the FDA stood firm in its defense of mRNA vaccine safety.

Keep reading

Unmasking the Contamination Crisis in mRNA Injectable Drugs: A Public Health Catastrophe in the Making

The alarm bells began to ring loudly when Kevin McKernan first uncovered alarmingly high levels of DNA contamination in early 2023, a finding that has since been corroborated by numerous independent scientists. The most recent revelation comes from a study conducted in a laboratory utilized by the FDA itself, exposing staggering levels of contamination in every analyzed vaccine lot. This discovery, particularly significant because of the FDA’s connection, suggests that the problem may be even worse than initially reported. Methodological limitations raise the possibility that larger, more dangerous DNA fragments capable of disrupting cellular functions remain undetected. Instead of taking responsibility, the FDA—the agency charged with safeguarding public health—has chosen to distance itself from these damning findings. By denying ownership of the study and refusing to act, the FDA has demonstrated a chilling disregard for public safety, prioritizing perception over accountability.

DNA contamination, even in small fragments, is far from a hypothetical risk confined to theoretical science. These fragments can trigger immune pathways like cGAS-STING,[1] leading to chronic inflammation and immune system dysregulation. The threat of genomic integration—where foreign DNA integrates into human cells—looms ominously, with potentially catastrophic consequences if it occurs in critical regions such as oncogenes or tumor suppressor genes. This risk is compounded by the lipid nanoparticles (LNPs) used in vaccine delivery, which protect these fragments and enhance their ability to enter human cells. The very mechanism designed to deliver the mRNA payload efficiently may inadvertently pave the way for these fragments to wreak havoc within the human body.

The FDA laboratory’s report indicated that the DNA contamination consisted of non-replicating fragments, which might appear less dangerous at first glance. The probability of genomic integration was estimated at approximately 1 in 10 million cells. While this figure may sound reassuringly small, the broader context reveals a much more alarming reality. The human body contains roughly 37 trillion cells, meaning that even such a low probability translates to an average of around 3,700 cells per individual potentially experiencing genomic integration. If foreign DNA integrates into critical genomic regions in just one of these cells,[2] the results could be catastrophic, leading to mutations that may escape immune detection and cause severe health outcomes over time.

When scaled to the billions of vaccinated individuals worldwide, the potential for population-wide health impacts becomes staggering. The sheer number of affected cells across global populations magnifies the risk of rare but severe reactions, challenging the dismissive assurances of safety provided by regulatory bodies. These are not merely theoretical risks; they are statistically plausible outcomes that demand immediate scrutiny and decisive action. The scale and scope of these potential outcomes should compel regulatory agencies and manufacturers to halt vaccine distribution until these dangers are fully understood and mitigated.

Keep reading

FDA’s Own Study Finds DNA Contamination in Pfizer Vaccines

A peer-reviewed study performed at a U.S. Food and Drug Administration (FDA) laboratory by high school students has confirmed the presence of a high level of DNA contamination in Pfizer’s mRNA COVID-19 vaccine.

The study, published Dec. 29, 2024, in the Journal of High School Science, was authored by three students at Centreville High School in Clifton, Virginia, and performed under the supervision of FDA scientists.

Maryanne Demasi, Ph.D., an investigative medical reporter, was the first to report on the study.

The research, performed at the FDA’s White Oak Campus in Maryland, found that levels of residual DNA in the Pfizer COVID-19 vaccine were 6 to 470 times higher than regulatory safety limits. The students tested two lots of the vaccine, finding they contained “residual DNA to a level that exceeds 10 ng [nanograms] per dose.”

“The potential health risk posed by residual small DNA fragments is currently unknown,” the study stated. However, the authors also said that DNA contamination may result in insertional mutagenesis — or DNA mutations — that can cause cancer.

Speaking last month on “The Defender In-Depth,” Kevin McKernan, who first identified DNA contamination in the shots in 2023, said DNA in vaccines can pose health risks because the DNA “could integrate into the genome and cause disruption of the genome … or it could disrupt other genes that are related to cancer.”

The FDA did not respond to multiple requests for comment on the study.

Keep reading

New Zealand media’s go-to source for expert opinions supports a bill to deregulate the use of genetic modification; Dr. Guy Hatchard responds

Guy Hatchard, PhD, was formerly Director of Natural Products at Genetic ID (now FoodChain ID) a global food safety testing and certification company. He presented to the original Royal Commission on Genetic Modification in New Zealand in 2000 which helped to clarify the safety ground rules and labelling requirements for genetically modified organisms (“GMOs”) which currently form a part of the New Zealand Hazardous Substances and New Organisms (“HSNO”) legislation. Dr. Hatchard is retired and has no financial interest in the outcomes of the current legislative initiative to deregulate biotechnology experimentation.

The following is his formal response to the Science Media Centre (“SMC”) – an “independent” source of information for the media on all issues related to research, science and innovation – which has published expert opinions in support of the Bill.

Keep reading

DNA Contamination In Pfizer COVID Vaccines Up To Four Times Legal Limits, Study Finds

Researchers found DNA in Pfizer’s COVID-19 vaccines at levels three-to-four times higher than regulatory limits, according to a new “bombshell” study.

“This far exceeds the maximal acceptable concentration of 10 ng [nanograms] per clinical dose that has been set by international regulatory authorities,” the authors wrote.

The peer-reviewed study, published this week in the journal Science, Public Health Policy and the Law, also found simian virus 40 (SV40) DNA contaminants in the vaccines. And the researchers determined that the spike proteins produced by the vaccines persist in the body longer than claimed.

The findings led the authors to call for “an immediate halt of all RNA biologicals.”

Karl Jablonowski, Ph.D., senior research scientist at Children’s Health Defense (CHD), told The Defender that DNA contamination may contribute to the increase in autoimmune diseases among the vaccinated. “The immune system operates on very sensitive detections to initiate responses,” he said.

“DNA suddenly deposited into your bloodstream could kickstart the interferon response,” Jablonowski said. “The interferon response, when there’s nothing to find but ‘self,’ could be the springboard for autoimmune disease.”

The study also showed that the spike proteins produced after vaccination persist in the body for at least seven days following vaccination instead of the shorter period Pfizer-BioNTech previously claimed. The spike proteins are also prone to shedding.

These results “raise grave concerns” about mRNA vaccines, the study concluded.

Kevin McKernan, founder of Medicinal Genomics, is the first scientist who identified the presence of SV40 in the mRNA vaccines. He called the new study “a tour de force on the DNA contamination topic.” McKernan wrote about the study on Substack, and said in an X post that the study’s authors “knocked it out of the park.”

Immunologist and biochemist Jessica Rose, Ph.D., agreed. “This paper is the paper of the century. The paper is not only a work of art in terms of the study layout. It is very well-written and settles ongoing ‘issues’ pertaining to allegations made by regulatory bodies that the DNA contamination issue is misinformation,” Rose said.

Keep reading

BioNTech RNA-Based COVID-19 Injections Contain Large Amounts Of Residual DNA Including An SV40 Promoter/Enhancer Sequence

Background: BNT162b2 RNA-based COVID-19 injections are specified to transfect human cells to efficiently produce spike proteins for an immune response.

Methods: We analyzed four German BNT162b2 lots applying HEK293 cell culture, immunohistochemistry, ELISA, PCR, and mass spectrometry.

Results: We demonstrate successful transfection of nucleoside-modified mRNA (modRNA) biologicals into HEK293 cells and show robust levels of spike proteins over several days of cell culture. Secretion into cell supernatants occurred predominantly via extracellular vesicles enriched for exosome markers. We further analyzed RNA and DNA contents of these vials and identified large amounts of DNA after RNase A digestion in all lots with concentrations ranging from 32.7 ng to 43.4 ng per clinical dose. This far exceeds the maximal acceptable concentration of 10 ng per clinical dose that has been set by international regulatory authorities. Gene analyses with selected PCR primer pairs proved that residual DNA represents not only fragments of the DNA matrices coding for the spike gene, but of all genes from the plasmid including the SV40 promoter/enhancer and the antibiotic resistance gene.

Conclusion: Our results raise grave concerns regarding the safety of the BNT162b2 vaccine and call for an immediate halt of all RNA biologicals unless these concerns can be dispelled.

Keep reading